UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Balancing the CAR T: perspectives on efficacy and safety of CAR T-cell therapy in hematologic malignancies

The American journal of managed care, 2021-08, Vol.27 (Suppl 13), p.S243-S252

Buie, Larry W

2021

Volltextzugriff (PDF)

Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia

Annals of hematology, 2016-12, Vol.95 (12), p.2009-2015

2016

Volltextzugriff (PDF)

Blinatumomab: A First-in-Class Bispecific T-Cell Engager for Precursor B-Cell Acute Lymphoblastic Leukemia

The Annals of pharmacotherapy, 2015-09, Vol.49 (9), p.1057

2015

Volltextzugriff (PDF)

National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey

JCO oncology practice, 2022-08, Vol.18 (8), p.OP2100883-e1296

2022

Volltextzugriff (PDF)

Vemurafenib‐Associated Pancreatitis: Case Report

Pharmacotherapy, 2013-04, Vol.33 (4), p.e43-e44

2013

Volltextzugriff (PDF)

Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers

British journal of cancer, 2022-04, Vol.126 (6), p.889-898

2022

Volltextzugriff (PDF)

Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells

Clinical nephrology, 2020-01, Vol.93 (1), p.42

2020

Volltextzugriff (PDF)

Expanding care through a layered learning practice model

American journal of health-system pharmacy, 2016-11, Vol.73 (22), p.1869-1875

2016

Volltextzugriff (PDF)

Successful Use of Octreotide as a Chemoprotectant for Prevention of PEG‐Asparaginase–Induced Pancreatitis

Pharmacotherapy, 2014-08, Vol.34 (8), p.e149-e151

2014

Volltextzugriff (PDF)

The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy

The Annals of pharmacotherapy, 2012-02, Vol.46 (2), p.276

2012

Volltextzugriff (PDF)

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia

The Annals of pharmacotherapy, 2018-03, Vol.52 (3), p.268

2018

Volltextzugriff (PDF)

A Study of Layered Learning in Oncology

American journal of pharmaceutical education, 2016-05, Vol.80 (4), p.68-68, Article 68

2016

Volltextzugriff (PDF)

The use of Erwinia Asparaginase for Adult Patients with Acute Lymphoblastic Leukemia after Pegaspargase Intolerance

Leukemia research, 2016-11, Vol.50, p.17-20

2016

Volltextzugriff (PDF)

Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners

Journal of oncology pharmacy practice, 2022-12, Vol.28 (8), p.1832-1847

2022

Volltextzugriff (PDF)

Nelarabine: A novel purine antimetabolite antineoplastic agent

Clinical therapeutics, 2007-09, Vol.29 (9), p.1887-1899

2007

Volltextzugriff (PDF)

Bevacizumab: a treatment option for recurrent glioblastoma multiforme

The Annals of pharmacotherapy, 2008-10, Vol.42 (10), p.1486

2008

Volltextzugriff (PDF)

Management of Menorrhagia Associated with Chemotherapy-Induced Thrombocytopenia in Women with Hematologic Malignancy

Pharmacotherapy, 2011-11, Vol.31 (11), p.1092-1110

2011

Volltextzugriff (PDF)

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

Journal of oncology pharmacy practice, 2021-03, Vol.27 (2), p.389-394

2021

Volltextzugriff (PDF)

Impact of a new assay for measuring serum creatinine levels on carboplatin dosing

American journal of health-system pharmacy, 2012-07, Vol.69 (13), p.1136-1141

2012

Volltextzugriff (PDF)

Successful Use of Intrathecal Carboxypeptidase G2 for Intrathecal Methotrexate Overdose: A Case Study and Review of the Literature

Clinical lymphoma, myeloma and leukemia, 2013-04, Vol.13 (2), p.166-170

2013

Volltextzugriff (PDF)

Allopurinol as adjuvant therapy in poorly responsive or treatment refractory schizophrenia

The Annals of pharmacotherapy, 2006-12, Vol.40 (12), p.2200

2006

Volltextzugriff (PDF)

National survey on the effect of oncology drug shortages in clinical practice: A Hematology Oncology Pharmacy Association (HOPA) survey

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e13609-e13609

2021

Volltextzugriff (PDF)

Choice of Hypomethylating Agent (HMA) for Initial Treatment Does Not Influence Outcome or Survival for Therapy-Related Myeloid Neoplasms (t-MN)

Blood, 2019-11, Vol.134 (Supplement_1), p.1718-1718

2019

Volltextzugriff (PDF)

Effect of Obesity on the Efficacy and Toxicities in Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) for Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.4617-4617

2018

Volltextzugriff (PDF)

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Blood, 2017-12, Vol.130, p.1950-1950

2017

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(46)
Berichte
(2)

Sprache

Englisch
(48)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(25)
Humans
(22)
Pharmacology & Pharmacy
(18)
Oncology
(13)
Female
(10)
Male
(10)
Middle Aged
(8)
Adult
(6)
Aged
(6)
Antineoplastic Agents - Adverse Effects
(6)
Antineoplastic Agents - Therapeutic Use
(6)
Patients
(6)
Pharmacy
(6)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Pharmacists
(5)
Pharmacology. Drug Treatments
(5)
Retrospective Studies
(5)
Chemotherapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Balancing the CAR T: perspectives on efficacy and safety of CAR T-cell therapy in hematologic malignancies

Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia

Blinatumomab: A First-in-Class Bispecific T-Cell Engager for Precursor B-Cell Acute Lymphoblastic Leukemia

National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey

Vemurafenib‐Associated Pancreatitis: Case Report

Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers

Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells

Expanding care through a layered learning practice model

Successful Use of Octreotide as a Chemoprotectant for Prevention of PEG‐Asparaginase–Induced Pancreatitis

The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia

A Study of Layered Learning in Oncology

The use of Erwinia Asparaginase for Adult Patients with Acute Lymphoblastic Leukemia after Pegaspargase Intolerance

Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners

Nelarabine: A novel purine antimetabolite antineoplastic agent

Bevacizumab: a treatment option for recurrent glioblastoma multiforme

Management of Menorrhagia Associated with Chemotherapy-Induced Thrombocytopenia in Women with Hematologic Malignancy

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

Impact of a new assay for measuring serum creatinine levels on carboplatin dosing

Successful Use of Intrathecal Carboxypeptidase G2 for Intrathecal Methotrexate Overdose: A Case Study and Review of the Literature

Allopurinol as adjuvant therapy in poorly responsive or treatment refractory schizophrenia

National survey on the effect of oncology drug shortages in clinical practice: A Hematology Oncology Pharmacy Association (HOPA) survey

Choice of Hypomethylating Agent (HMA) for Initial Treatment Does Not Influence Outcome or Survival for Therapy-Related Myeloid Neoplasms (t-MN)

Effect of Obesity on the Efficacy and Toxicities in Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) for Lymphoma

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Suchergebnisse filtern